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Presentation and outcome of critically ill medical and
cardiac-surgery patients with acute heart failure
Abstract
BACKGROUND: The aim of the study was to investigate presentation and outcome of consecutive
acute heart failure (AHF) patients admitted to the intensive care unit (ICU) including also patients
undergoing cardiac surgery, thereby providing comparative information on all critically ill AHF
subgroups. METHODS: The prospective observational study with 6-month follow up was performed in
the cardio-thoracic and the medical ICU of a university hospital. AHF was defined according to the
European Society of Cardiology guidelines. Univariate Cox regression was used to calculate hazard
ratio (HR) and 95% confidence intervals (CI) for risk factors. RESULTS: A total of 192 patients
fulfilled the AHF criteria, of whom 86 and 24 underwent elective and emergency cardiac surgery,
respectively. The remaining 82 medical patients had no surgical interventions. Cardiogenic shock was
diagnosed in 32% of all patients and was the most common AHF presentation. Medical, elective surgery
and emergency surgery AHF patients had a mortality at 30 days of 31%, 4.7% and 22% (<0.05) and at
180 days of 42%, 6.1% and 23% (<0.05), respectively. While the presence of cardiogenic shock was
associated with a poor outcome (HR 1.8, CI 1.0-3.0; p=0.04), post-operative cardiac stunning had a
good prognosis (HR 0.06, CI 0.01-0.47; p<0.01). Mortality worsened when infections (HR 2.8, CI
1.5-5.7; p<0.01) or renal dysfunction (HR 4.4, CI 2.2-8.4, p<0.01) were present on ICU admission.
CONCLUSIONS: Medical patients, patients undergoing elective cardiac surgery and patients requiring
emergency cardiac surgery are three distinct AHF-subpopulations. Co-morbidities and surgical
treatment options affect long-term outcome.
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Background: The aim of the study was to in-
vestigate presentation and outcome of consecu-
tive acute heart failure (AHF) patients admitted
to the intensive care unit (ICU) including also pa-
tients undergoing cardiac surgery, thereby pro-
viding comparative information on all critically ill
AHF subgroups.
Methods: The prospective observational study
with 6-month follow up was performed in the car-
dio-thoracic and the medical ICU of a university
hospital. AHF was defined according to the Euro-
pean Society of Cardiology guidelines. Univariate
Cox regression was used to calculate hazard ratio
(HR) and 95% confidence intervals (CI) for risk
factors.
Results: A total of 192 patients fulfilled the
AHF criteria, of whom 86 and 24 underwent elec-
tive and emergency cardiac surgery, respectively.
The remaining 82 medical patients had no surgi-
cal interventions. Cardiogenic shock was diag-
nosed in 32% of all patients and was the most
commonAHF presentation.Medical, elective sur-
gery and emergency surgery AHF patients had
a mortality at 30 days of 31%, 4.7% and 22%
(p <0.05) and at 180 days of 42%, 6.1% and 23%
(p <0.05), respectively.While the presence of car-
diogenic shock was associated with a poor out-
come (HR 1.8, CI 1.0–3.0; p = 0.04), post-opera-
tive cardiac stunning had a good prognosis (HR
0.06, CI 0.01–0.47; p <0.01). Mortality worsened
when infections (HR 2.8, CI 1.5-5.7; p <0.01) or
renal dysfunction (HR 4.4, CI 2.2–8.4, p <0.01)
were present on ICU admission.
Conclusions: Medical patients, patients under-
going elective cardiac surgery and patients requir-
ing emergency cardiac surgery are three distinct
AHF-subpopulations. Co-morbidities and surgi-
cal treatment options affect long-term outcome.
Key words: acute heart failure; cardiogenic shock;
cardiac surgery; intensive care unit; mortality
Summary
Acute heart failure (AHF) is a common clini-
cal entity associated with a high morbidity and
mortality [1–4]. When the AHF symptoms be-
come so severe that affected patients require con-
tinuous monitoring and organ support, medical
management is usually provided in the intensive
care unit (ICU). Many AHF patients will further
need emergency cardiac surgery during the
course of their illness. Others develop AHF
symptoms after undergoing elective cardiac sur-
gery. However, only one study provides details on
ICU patients with AHF [5], while others do not
specifically comment on patients hospitalised in
the ICU [6–10]. A limitation common to all these
epidemiological studies is that they do not partic-
ularly report on the subgroup of AHF patients re-
quiring cardiac surgery.
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The aim of this study was to provide compar-
ative information on a broad range of AHF syn-
dromes in critically ill patients, including those
undergoing cardiac surgery. We therefore as-
sessed population characteristics of consecutive
AHF patients admitted to the medical and cardio-
surgical ICU. In addition, we investigated short
and long-term outcome of our critically ill AHF
population and assessed risk factors influencing
mortality.
Methods
Study population
We conducted a prospective observational study,
using an identical evaluation protocol, at the 12-bed med-
ical ICU and at the 10-bed cardiac surgery ICU of the
University Hospital Zurich, Switzerland. Consecutive pa-
tients were screened for the diagnosis of AHF on the day
of their ICU admission. Patients were included in the
analysis only once, even if they were readmitted during
the observation period.The study was carried out in com-
pliance with the Helsinki Declaration. Patients and/or
their relatives gave their oral informed consent for the
anonymous analysis of the collected routine clinical and
laboratory data. The Institutional Review Board waived
the need for written informed consent in this particular
instance.
Diagnosis of acute heart failure
AHF is defined as the rapid onset of symptoms and
signs secondary to abnormal cardiac function, which is
described as the inability to pump sufficient blood at nor-
mal end-diastolic pressures. Our classification was
adapted from the AHF guidelines provided by the Euro-
pean Society of Cardiology and the European Society of
Intensive Care Medicine [11].We included the following
distinct clinical conditions:
– Cardiogenic shock: Low cardiac output (<2.2 l/
min/m
2
) with or without low BP after correction of
preload, with evidence of tissue hypoperfusion or
organ dysfunction.
– Post-operative cardiac stunning: Transient and re-
versible impairment of contractility after cardiac sur-
gery, resulting in low cardiac output after correction
of preload, with need for inotropic support in order
to prevent tissue hypoperfusion and organ dysfunc-
tion.
– Pulmonary oedema: Heart failure induced severe
respiratory distress, accompanied by crackles over
both lungs and bilateral infiltrates in the chest X-ray.
– Congestive heart failure: All other conditions with
AHF signs and symptoms, which do not fulfill the di-
agnostic criteria for the AHF syndromes described
above, e.g. during the observation period after
myocardial infarction. No particular distinction be-
tween left-, right-, and biventricular failure was un-
dertaken.
In addition, we identified patients with sepsis-in-
duced cardiac dysfunction, which required inotropic sup-
port due to an impaired left ventricular ejection fraction
or low cardiac output. It is important to note that we did
not diagnose AHF by elevated natriuretic peptide levels
alone as it has been shown that these markers have a lim-
ited specificity in critically ill patients [12–14].
Case definition
AHF patients were divided into surgical and medical
sub-groups, whether or not they had heart surgery pre-
ceding or during the ICU stay. Surgical patients were
divided in two groups whether they underwent elective
surgery or emergency (= non-elective) operations. My-
ocardial infarction (MI) was diagnosed in the presence of
coronary artery disease, typical ECG changes and ele-
vated (≥0.1 mg/l) troponin T levels. Clinical and labora-
tory data were recorded on the day of ICU admission.
Like in the Euro Heart Failure Survey II, renal dysfunc-
tion was defined as serum creatinine levels >177 mmol/l
(>2 mg/dl) [7]. Data for the Simplified Acute Physiology
Score II (SAPS II) were collected as the worst value
within 24 hours after ICU-admission [15]. Left ventricu-
lar ejection fraction was determined by echocardiography
or ventriculography 24 hours prior or during the ICU
stay.
Statistics
Group comparison for continuous variables was
tested with the Mann Whitney U test and categorical
variables were compared with the chi-square test. Sur-
vival estimates for all cause mortality were calculated with
the method of Kaplan and Meier. The Log Rank test was
used to compare the mortality subgroups. Hazard ratio
(HR) and 95% confidence intervals (CI) for risk factors
influencing mortality were calculated with a univariate
Cox regression model. All tests were performed with the
use of SPSS 11.0.4 for Mac OS X.
Results
Patient characteristics
During the 3-month observation period 355
consecutive ICU-admissions were screened for
the diagnosis of AHF. One hundred and seventy-
two patients out of 355 (48%) were treated with-
out surgery and classified as medical patients. Of
the 172 medical patients 82 (48%) fulfilled the
diagnosis of AHF. One hundred and eighty-three
of 355 (52%) patients underwent cardiac surgery
and were classified as surgical patients, and AHF
was diagnosed in 110/183 (61%). Of the 110 sur-
gical patients 86 (78%) underwent elective cardiac
surgery and 24 (22%) required emergency cardiac
surgery.
Baseline characteristics for the three groups
of AHF patients are shown in table 1. A history of
chronic heart failure was present in 34% of med-
ical patients, 57% of patients undergoing elective
cardiac surgery and 4.2% of patient requiring
emergency cardiac surgery (p <0.01 between
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groups). Cardiac operations were performed
under extracorporeal circulation (ECC) in 90/110
(82%) surgical patients. Coronary artery bypass
grafting, the most frequent operation, was per-
formed in 50% of surgical AHF patients. Other
surgical procedures included aortic valve replace-
ment (24%), mitral valve repair (15%), mitral
valve replacement (5.5%), and pericardial
drainage (4.5%). Five patients (4.5%) received a
left ventricular assist device or a heart transplant
prior or during their ICU stay. Regarding these
frequencies, no differences were found between
elective and emergency surgery patients. Major
vascular surgery was performed alone in 6.4%
and combined with heart surgery in 8.2% of sur-
gical AHF patients. On ICU admission, inotropes
were used significantly more often (p <0.01) in
elective surgery (63%) and emergency surgery
patients (54%) than in medical (21%) patients.
Similarly, vasopressors were required significantly
(p <0.01) more often in elective surgery (70%)
and emergency surgery (63%) patients than in
medical patients (33%).
Table 2 shows the frequencies of the different
AHF syndromes as well as values of selected clin-
ical and laboratory parameters. Surgical patients
pre-treated with beta-blockers, ACE-inhibitors or
angiotensin II-antagonists did not present more
frequently with low output syndrome or shock
than patients without medical pre-treatment.
Organ dysfunction for the three groups is dis-
played in table 3. Left ventricular ejection frac-
tion was 40 (10–75)% and not statistically differ-
ent between the three groups. SAPS II was 31 (6–
84) in medical patients and 22 (6–52) in elective
surgery patients with a significant difference be-
tween the two groups (p <0.01). Patients undergo-
ing emergency surgery had SAPS II of 27 (12–84),
which was also significantly higher compared to
the scores of patients undergoing elective cardiac
surgery (p <0.01).
Outcome and risk factors
Length of ICU stay was significantly shorter
in medical patients (3 (1–30) days; p <0.01) and in
elective surgery patients (3 (1–83) days; p <0.01)
than in emergency surgery patients (6.5 (2–38)
days). The average length of hospital stay though
was 11 (2–170) days and not different between the
three groups. Survival curves for the three AHF
populations are displayed in figure 1. Medical,
elective surgery and emergency surgery AHF pa-
tients had a mortality at 30-days of 31%, 4.7%
and 22% (p <0.05) and at 180-days of 42%, 6.1%
Medical AHF- AHF patients AHF-patients p-value p-value p-value
patients with with emergency (medical vs (medical vs (elective vs
(n = 82) elective surgery surgery elective emergency emergency
(n = 86) (n = 24) surgery) surgery) surgery
Patient characteristics:
Age (years) – median (range) 66 (30-96) 67 (18-85) 59 (28-84) 0.985 0.349 0.352
Male sex 55 (67%) 56 (65%) 20 (83%) 0.871 0.201 0.133
Underlying cardiac disease:
Coronary artery disease 57 (70%) 53 (62%) 12 (50%) 0.331 0.092 0.352
Cardiac valve disease 15 (18%) 47 (55%) 11 (46%) <0.001 0.013 0.494
Hypertensive cardiomyopathy 8 (9.8%) 15 (17%) 1 (4.2%) 0.180 0.680 0.187
Dilated cardiomyopathy 7 (8.5%) 8 (9.3%) 2 (8.3%) 1.000 1.000 1.000
Precipitating factors:
STEMI 26 (32%) 3 (3.5%) 3 (13%) <0.001 0.073 0.117
Non-STEMI 16 (20%) 28 (33%) 6 (25%) 0.079 0.574 0.619
Systolic BP >150 mm Hg 9 (11%) 3 (3.7%) 1 (4.3%) 0.131 0.687 1.000
Infection on ICU-admission 20 (24%) 0 (0.0%) 6 (25%) <0.001 1.000 <0.001
Underlying diseases:
Systemic arterial hypertension 36 (44%) 43 (50%) 16 (67%) 0.444 0.064 0.171
Diabetes mellitus 22 (27%) 11 (13%) 3 (13%) 0.032 0.180 1.000
Chronic lung disease 9 (11%) 19 (22%) 1 (4.2%) 0.064 0.450 0.069
Drug history:
Betablockers 31 (38%) 54 (63%) 6 (25%) 0.002 0.332 0.001
ACE inhibitors 24 (29%) 43 (51%) 7 (29%) 0.007 1.000 0.069
AT II inhibitors 10 (12%) 10 (12%) 2 (8.3%) 1.000 0.730 1.000
Statins 27 (33%) 43 (50%) 4 (17%) 0.029 0.201 0.005
Diuretics 34 (42%) 44 (51%) 8 (33%) 0.220 0.636 0.166
Aldactone 11 (13%) 14 (16%) 0 (0%) 0.668 0.066 0.037
Age is displayed as median (range), all other values represent number of patients (percentage of patients). STEMI denotes ST-elevation
myocardial infarction, BP blood pressure, ACE angiotensin converting enzyme, and AT angiotensin.
Table 1
Baseline
characteristics.
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Medical AHF- AHF patients AHF-patients p-value p-value p-value
patients with with emergency (medical (medical vs (elective vs
(n = 82) elective surgery surgery vs elective emergency emergency
(n = 86) (n = 24) surgery) surgery) surgery
AHF syndromes:
Cardiogenic shock 18 (22%) 28 (33%) 16 (67%) 0.166 <0.001 0.004
Pulmonary oedema 25 (31%) 1 (1.2%) 1 (4.2%) <0.001 0.012 0.390
Congestive heart failure 33 (40%) 18 (21%) 5 (21%) 0.007 0.093 1.000
Post-operative cardiac stunning 0 (0.0%) 39 (45%) 2 (8.3%) <0.001 0.051 0.001
Sepsis-induced cardiac depression 6 (7.3%) 0 (0.0%) 0 (0.0%) 0.012 0.333 –
Parameters on ICU admission:
Respiration rate (1/min)
A
20 (12–60) 13 (10–30) 15 (9–35) <0.001 0.021 0.004
Heart rate (1/min) 85 (30–180) 88 (32–120) 92 (50–140) 0.664 0.737 0.403
Mean arterial BP (mm Hg) 80 (42–180) 70 (50–110) 75 (50–100) 0.025 0.337 0.687
CVP (mm Hg)
B
12 (2–22) 9 (1–17) 10 (5–26) 0.002 0.987 0.060
Urine output (ml/h)
C
60 (0–480) 115 (0–340) 90 (0–200) <0.001 0.137 0.034
Laboratory parameters:
Haemoglobin (g/l) 118 (55-197) 96 (31-175) 99 (75–175) <0.001 0.045 0.506
Leukocyte count (1/μl) 11245 8500 9655 <0.001 0.234 0.155
(790–54790) (3670–20870) (4670–27950)
Troponin (μg/l)
D
0.31 (0.01–24) 0.29 (0.01–2.7) 0.32 (0.01–27) 0.198 0.900 0.584
NT-proBNP (ng/l)
E
4337 2371 4934 0.080 0.712 0.022
(138–70000) (390–13’702) (1000–33335)
C-reactive protein (mg/l)
F
28 (1.0–316) 11 (1.0–136) 52 (5.0–365) 0.012 0.052 <0.001
Creatinine (μmol/l)
G
102 (57–2277) 82 (49–144) 111 (57–567) <0.001 0.571 <0.001
Values represent number (percentages) or median (range). BP denotes blood pressure, CVP central venous pressure, and NT-proBNP
N-terminal pro B-type natriuretic peptide. Values for calculations were available in
A
62 (not intubated),
B
135,
C
173,
D
184,
E
97,
F
176 and
G
185 patients.
Table 2
Clinical presentation
of AHF.
Medical AHF- AHF patients AHF-patients p-value p-value p-value
patients with with emergency (medical (medical vs (elective vs
(n = 82) elective surgery surgery vs elective emergency emergency
(n = 86) (n = 24) surgery) surgery) surgery
Cardiovascular dysfunction:
Mean arterial BP <65 mm Hg 14 (17%) 14 (17%) 6 (25%) 1.000 0.390 0.375
Cardiac index ≤2.2 l/min/m
2 A
4 (33%) 33 (50%) 5 (42%) 0.356 1.000 0.756
LV ejection fraction <40%
B
14 (48%) 12 (24%) 5 (36%) 0.046 0.523 0.495
Respiratory dysfunction:
Arterial pO
2
/FiO
2
<300 mm Hg
C
42 (78%) 30 (40%) 13 (65%) <0.001 0.369 0.047
Renal dysfunction:
Creatinine >177 μmol/l 18 (23%) 0 (0.0%) 3 (13%) <0.001 0.390 0.011
(>2.0 mg/dl)
D
Metabolic dysfunction:
Glucose ≥11.1 mmol/l
E
14 (18%) 4 (4.9%) 4 (17%) 0.011 1.000 0.076
Values represent number of patients (percentage of patients). BP denotes blood pressure, LV left ventricular, paO
2
/FiO
2
arterial
partial pressure of oxygen per fraction of inspired oxygen. Values for calculations were available in
A
90,
B
93,
C
150,
D
185 and
E
183 patients.
Table 3
Organ dysfunction.
and 23% (p <0.05), respectively. Figure 2 shows
survival curves for the various AHF syndromes.
Cardiogenic shock was associated with an un-
favourable outcome (HR 1.8, CI 1.0–3.0; p =
0.04), particularly in medical patients, who had a
180-day mortality of 72% (compared to 20% in
surgical patients; p <0.01). In contrast, post-oper-
ative cardiac stunning had a good prognosis (HR
0.06, CI 0.01–0.47; p <0.01). Six patients had sep-
sis-induced myocardial depression, and only 3
(50%) of them were still alive at 6 months. Infec-
tions on admission generally increased the risk of
death (HR 2.8, CI 1.5–5.7; p <0.01).Mortality was
lower in patients pre-treated with beta-blockers
(HR 0.5, CI 0.3–1.0; p = 0.04) and statins (HR 0.4,
CI 0.2–0.8; p = 0.01), while the use of ACE in-
hibitors was not associated with any statistically
significant effect.
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Figure 1
The Kaplan Meier
curves show survival
rates for three groups
of ICU-patients with
acute heart failure
over time, starting at
the day of ICU admis-
sion.The small verti-
cal lines indicate the
time points when
patients had their
last follow up.The
survival curves
between the three
groups were signifi-
cantly different
(Log Rank p <0.001).
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Figure 2
The Kaplan Meier
curves show survival
rates of ICU-patients
with different acute
heart failure syn-
dromes over time,
starting at the day
of ICU admission.The
small vertical lines in-
dicate the time points
when patients had
their last follow up.
The survival curves
between the groups
were significantly
different (Log Rank
p <0.001).The 6 pa-
tients with sepsis-
induced myocardial
depression are not
included in this
graph.
Post-operative cardiac
stunning (n = 41)
Congestive HF (n = 56)
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Figure 3
Univariate risk fac-
tors for mortality.
Bars represent haz-
ard ratios with 95%
confidence intervals.
A value >1.0 indicates
an increased risk
of mortality, a value
<1.0 denotes a risk
reduction. Bars cross-
ing 1.0 do not reach
statistical signifi-
cance. LV denotes left
ventricular, CVP cen-
tral venous pressure,
BP blood pressure,
p
a
O
2
/F
i
O
2
arterial par-
tial pressure of oxy-
gen per fraction of
inspired oxygen, and
NT-proBNP N-termi-
nal pro B-type
natriuretic peptide.
LV ejection fraction <40%
CVP >15 mm Hg
Mean arterial BP <65 mm Hg
Heart rate >100/min
Respiration rate >18/min
p
a
O
2
/FiO
2
<300 mm Hg
Creatinine >177 μmol/l (>2 mg/dl)
Glucose ≥11.1 mmol/l
NT-proBNP ≥4500 ng/l
C-reactive protein ≥20 mg/l
Leukocyte count ≥10 000/μl
0.1 1.0 10.0
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The present study investigated consecutive
AHF patients admitted to the ICU including also
patients undergoing cardiac surgery, thereby pro-
viding for the first time comparative information
on all critically ill AHF subgroups. Our results
demonstrate that medical patients, patients under-
going elective cardiac surgery and patients requir-
ing emergency cardiac surgery are three distinct
AHF-subpopulations. Co-morbidities, organ dys-
function, and surgical treatment options deter-
mined long-term outcome.The following sections
elucidate important differences between medical
and cardio-surgical patients andput them into con-
text with the risk of death.
Patient characteristics
In our ICU study population mortality was
highest in medical AHF patients.A similar 4-week
mortality (27%) was found in a multi-centre sur-
vey investigating 581 ICU patients in whom ex-
perts diagnosed acute decompensated heart failure
from the patients’ charts [5]. However, 33% of
these patients had a history of cardiac surgery
and/or percutaneous coronary intervention, but
this sub-population was not analysed separately. In
ourmedical patientsAHFwasmost frequently a de
novo diagnosis.This stands in contrast to a general
heart failure population inwhich de novoAHFwas
diagnosed in only one third of the patients [1].Pul-
monary oedema and congestive heart failure were
the most common presentations in medical AHF
patients.Sepsis-induced cardiac depressionwas re-
sponsible only for a minority of AHF cases and ac-
companied by a poor outcome.
Elective surgery patients had the lowest mor-
tality. Firstly, they were more commonly pre-
treatedwith beta-blockers and statins.This reflects
optimised treatment prior to elective surgery. Sec-
ondly, surgical patients more frequently had a
valvular pathology as the underlying cardiac dis-
ease, amenable to surgical treatment.Furthermore,
elective cardiac patients had no infections on ICU
admissions and the lowest rateof renal dysfunction.
Finally, elective surgery patients presented fre-
quently with post-operative cardiac stunning.Un-
derlying mechanisms include reversible myocar-
dial depression due to inflammatory activation af-
ter extracorporeal circulation and surgical trauma,
anaesthetic medication, and transient hypother-
mia.
Precipitating factors and interventions
Elevated laboratory parameters of inflamma-
tionwere related to increasedmortality which sup-
ports recent studies investigating the use of C-re-
active protein levels [16] or leukocyte counts in
AHFpatients [17]. It has been suggested that an ac-
tivation of the inflammatory cascade contributes to
the pathophysiology of heart failure [18]. The
question remains how much infections contribute
to theobserved rise in inflammatorymarkers in this
condition.Inour study,clinically evident infections
on ICU admission had a negative impact on mor-
tality.As infections furtherdepress cardiac function
[19] more research is needed to understand the in-
teraction between heart failure and infections.
While elective surgery was accompanied by a
lowriskof death,mortality increasedwhenpatients
had to undergo emergency surgery.Typical indica-
tions for emergency surgery included repair ofme-
chanical complications after myocardial infarction
and bypass grafting in patients not suitable for a
percutaneous coronary intervention. Intravenous
drug treatment with inotropes was more frequent
in surgical patients than inmedical patients. In fact,
many surgical patients required inotropes during
surgery and in their first hours after ICUadmission
due to a low cardiac output. In patients undergoing
elective cardiac surgery, inotropes were frequently
administered to prevent tissue hypoperfusion and
organ dysfunction. These patients were classified
as post-surgical cardiac stunning,which is a partic-
ular form ofAHF generally associated with a rapid
improvement and a low mortality. In patients re-
quiring emergency surgery, however, inotropes
were frequently needed to treat cardiogenic shock
accompanied by organ dysfunction.
Organ dysfunction
Patients with cardiogenic shock had a high
mortality. However, their overall 180-day mortal-
ity of less than 40%was lower than in earlier stud-
ies performed in general [1, 2, 7] and ICU patients
[5] with AHF. This is because the majority of car-
diogenic shock patients included in the present
study had a surgical treatment option. In medical
patients, the relationship between low systolic
blood pressure and poor prognosis has previously
been reported [10, 20]. A creatinine serum level
>177mmol/l indicating renal function impairment
was associated with an adverse outcome, too.This
result supports previous findings that renal dys-
function has a negative impact on survival in AHF
patients and inpatients undergoing cardiac surgery
[1, 21–23].
Limitations of the study
It is important tonote,thatAHFwasdiagnosed
onICUadmission.Somesurgicalpatientshad their
operation before ICU admission (usually elective
cardiac surgery).Others were admitted to the ICU
first and had their operations later in the ICU
course (usually emergency cardiac surgery). Our
observational study was designed to monitor diag-
nostic procedures and treatments of AHF-patients
in our institution. Hence, some laboratory values
are lacking because the treating physician did not
consider them to be necessary for themanagement
of the patient. Similarly, echocardiographywas not
routinely performed while the patients were hos-
pitalised in the ICU. Other parameters such as
blood pressure or cardiac output are clearly influ-
Discussion
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enced by ongoing treatment and must be inter-
preted with caution. We used multiple univariate
testing for the exploration of differences between
groups and for possible risk factors influencing
mortality. Although useful for hypothesis genera-
tion, this approach increases the risk of type 1 er-
rors andmight explain differences to other studies.
Larger studies are needed to investigate complex
interactions between risk factors.
Conclusions
This prospective observational study per-
formed in a medical and cardio-surgical ICU con-
firms that medical patients, patients with elective
surgery and patients with emergency surgery are
three distinct AHF-populations. Co-morbidities,
organ dysfunction, and surgical treatment options
affect their mortality. The results of this study
provide essential background information for
larger multi-centre studies and future therapeutic
trials in critically ill patients with AHF.
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